1,315 results on '"Hirsch, Pierre"'
Search Results
2. Multi-target measurable residual disease assessed by error-corrected sequencing in patients with acute myeloid leukemia: An ALFA study
3. Reduced peripheral blood dendritic cell and monocyte subsets in MDS patients with systemic inflammatory or dysimmune diseases
4. Global serum profiling: an opportunity for earlier cancer detection
5. Modulation of bone marrow and peripheral blood cytokine levels by age and clonal hematopoiesis in healthy individuals
6. A Phase II prospective trial of azacitidine in steroid-dependent or refractory systemic autoimmune/inflammatory disorders and VEXAS syndrome associated with MDS and CMML
7. Aberrant DNA methylation impacts HOX genes expression in bone marrow mesenchymal stromal cells of myelodysplastic syndromes and de novo acute myeloid leukemia
8. Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study
9. Comparative effectiveness and risk of preterm birth of local treatments for cervical intraepithelial neoplasia and stage IA1 cervical cancer: a systematic review and network meta-analysis
10. Long‐term assessment of haematological recovery following somatic genetic rescue in a MYSM1‐deficient patient: Implications for in vivo gene therapy.
11. Germline ATG2B/GSKIP-containing 14q32 duplication predisposes to early clonal hematopoiesis leading to myeloid neoplasms
12. Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia.
13. Author Correction: JAK2V617F mutation drives vascular resident macrophages toward a pathogenic phenotype and promotes dissecting aortic aneurysm
14. JAK2V617F mutation drives vascular resident macrophages toward a pathogenic phenotype and promotes dissecting aortic aneurysm
15. Treatment methods for cervical intraepithelial neoplasia in England: A cost‐effectiveness analysis
16. The t(X;20)(q13;q13) translocation is a good prognostic factor in myeloid neoplasms: A report of 25 cases from the Groupe Francophone de Cytogénétique Hématologique
17. Invasive cervical cancer following treatment of pre-invasive lesions: A potential theory based on a small case series
18. Detection of ovarian cancer (± neo-adjuvant chemotherapy effects) via ATR-FTIR spectroscopy: comparative analysis of blood and urine biofluids in a large patient cohort
19. High prevalence of clonal hematopoiesis in the blood and bone marrow of healthy volunteers
20. Endometrial cancer patients’ preferences for follow-up after treatment: A cross-sectional survey
21. Exploring the acceptability and feasibility of patient-initiated follow-up for women treated for stage I endometrial cancer
22. Clonal dominance is an adverse prognostic factor in acute myeloid leukemia treated with intensive chemotherapy
23. A comparative analysis of different biofluids towards ovarian cancer diagnosis using Raman microspectroscopy
24. Need for early,minimally invasive cancer diagnosis
25. Fractionated gemtuzumab ozogamicin in association with high dose chemotherapy: a bridge to allogeneic stem cell transplantation in refractory and relapsed acute myeloid leukemia
26. ATR-FTIR Spectroscopy Tools for Medical Diagnosis and Disease Investigation
27. Very short insertions in the FLT3 gene are of therapeutic significance in acute myeloid leukemia
28. Raman spectroscopic techniques to detect ovarian cancer biomarkers in blood plasma
29. Control in dormancy or eradication of cancer stem cells: Mathematical modeling and stability issues
30. Standardization of complex biologically derived spectrochemical datasets
31. Differential diagnosis of Alzheimer’s disease using spectrochemical analysis of blood
32. BGCS uterine cancer guidelines: Recommendations for practice
33. A Clinicopathological Description of Kidney Features in VEXAS Syndrome
34. British Gynaecological Cancer Society recommendations and guidance on patient-initiated follow-up (PIFU)
35. Synchrotron- and focal plane array-based Fourier-transform infrared spectroscopy differentiates the basalis and functionalis epithelial endometrial regions and identifies putative stem cell regions of human endometrial glands
36. Cost-Consequence Analysis Alongside a Randomised Controlled Trial of Hospital Versus Telephone Follow-Up after Treatment for Endometrial Cancer
37. Characterization of genetic variants in the EGLN1/PHD2 gene identified in a European collection of patients with erythrocytosis
38. Advancing cervical cancer diagnosis and screening with spectroscopy and machine learning
39. Supplementary Table S7 from Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism
40. Data from Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism
41. Supplementary Methods and Supplementary Figures 1 through 18 from Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism
42. Clinical and pathological features of cutaneous manifestations in VEXAS syndrome: A multicenter retrospective study of 59 cases
43. Advancing cervical cancer diagnosis and screening with spectroscopy and machine learning
44. Advancing cervical cancer diagnosis and screening with spectroscopy and machine learning
45. Spatial and temporal age-related spectral alterations in benign human breast tissue
46. Very short insertions in the FLT3 gene are of therapeutic significance in acute myeloid leukemia
47. An analysis of benign human prostate offers insights into the mechanism of apocrine secretion and the origin of prostasomes
48. Somatic genetic alterations predict hematological progression in GATA2 deficiency
49. Clinical and pathological features of cutaneous manifestations in VEXAS syndrome: A multicenter retrospective study of 59 cases
50. Prognosis of body mass index and chemotherapy dose capping in acute myeloid leukaemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.